Breast screening is rapidly moving into an era of personalized care, where prevention, early detection, and treatment are guided by risk assessment.
The need for greater participation in breast cancer screening programs cannot be overlooked. An estimated 1 in 8 women will develop breast cancer in her lifetime.
Katie Kaminski, MRT (R), is the lead mammography technologist for Mayfair Diagnostics in Alberta, Canada. Katie has been with Mayfair since 2012 and is responsible for maintaining Mayfair’s screening and...
The recommended frequency of breast cancer screening and the age at which a woman should begin mammography remain sources of considerable debate.
Last week, the United States’ Food and Drug Administration (FDA) agency proposed a rule that would inform women of their breast density.
We are very excited to share our newest white paper, Improved Surgical Outcomes and Breast Implant Selection, Application of Automated Volumetric Breast Measurements, authored by Drs. Monica Saini and Ariane Chan.
Dr. Cathrine Keller is the President and Managing Physician of Lake Medical Imaging, a full-service diagnostic imaging practice.
Volpara and image analysis developer ScreenPoint Medical have signed an MOU which will see the two companies seek to bring ScreenPoint’s artificial intelligence–based Transpara detection and decision support software to...
The US Food and Drug Administration (FDA) is moving to improve the quality of mammography and provide more health information to patients, especially in the area of breast density, which...
Volpara’s Board meets in person at RSNA to do a complete strategic review of the company, with a view to the FY2020 budget and beyond.